台股 » 個股 » 慧智 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

慧智

(6615)
  • 股價
    48.55
  • 漲跌
    ▼0.85
  • 漲幅
    -1.72%
  • 成交量
    79
  • 產業
    上櫃 生技醫療類股
  • 42人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
慧智 (6615)籌碼相關-元大-板橋三民 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-板橋三民 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/21149.0500.0049.051941.06%
2024/05/17148.80149.2048.800900.00%
2024/05/15145.50145.3045.650850.00%
2024/05/14142.25143.0543.300870.00%
2024/05/1300.00143.5043.50-188-1.13%
2024/05/07148.2000.0048.301831.20%
2024/05/0600.00150.8049.35-181-1.22%
2024/05/03148.00148.9048.900760.00%
2024/05/0200.00147.6549.50-174-1.35%
2024/04/3000.00146.9045.00-166-1.51%
2024/04/29246.0800.0045.402663.03%
2024/04/2500.00144.9548.40-159-1.67%
2024/04/24143.6500.0044.001541.84%
2024/03/2900.00141.6041.00-135-2.84%
2024/03/27141.1500.0041.201342.87%
2024/03/1800.00141.0541.20-135-2.82%
2024/03/14140.6000.0040.901352.84%
2024/03/0600.00142.6042.65-134-2.87%
2024/02/29142.0500.0041.701342.90%
2024/01/1900.00344.0044.70-320-14.45%
2024/01/1500.00140.4043.50-115-6.49%
2024/01/09139.8500.0039.501137.24%
2023/12/2700.00140.9540.55-114-6.90%
2023/12/22140.4500.0040.851147.13%
2023/12/1800.00139.8540.60-113-7.28%
2023/12/15139.2500.0039.251137.43%
2023/10/12138.6000.0038.851362.73%
2023/09/22239.8000.0040.352385.15%
2023/03/0900.00138.2538.00-113-7.39%
2023/02/08236.7000.0036.8021414.10%
2022/06/22145.3000.0045.001128.26%
2022/05/18144.2000.0044.201127.87%
2022/01/17247.5000.0047.9521711.33%
2021/01/2500.00251.0051.00-29-21.43%
2020/11/1000.00156.1056.00-18-11.76%
2020/10/1300.00157.5057.50-115-6.65%
2020/07/10165.1000.0065.001402.45%
2020/07/06267.2500.0068.702395.01%
2020/06/2400.00167.5067.50-139-2.56%
2020/06/18170.5000.0069.501392.56%
2020/03/2300.00249.3048.60-241-4.87%
2020/03/2000.00551.2451.20-541-12.07%
2020/01/30163.6000.0062.101631.58%
2020/01/14168.8000.0068.801621.60%
2020/01/10366.8000.0066.503634.71%
2020/01/0300.00268.8069.20-264-3.09%
2019/11/28277.2000.0077.502633.17%
2019/07/1800.00196.1096.40-178-1.27%
2019/07/12189.6000.0091.401701.41%
2019/07/0900.00190.6090.00-168-1.45%
2019/07/02188.2000.0093.501661.50%
2019/04/0800.001105.50106.00-1176-0.57%
2019/04/0300.001106.50106.50-1177-0.56%
2019/04/021107.5000.00106.5011770.56%
2019/04/011108.5000.00107.5011760.57%
2019/03/2900.001109.50112.00-1176-0.57%
2019/03/271105.5000.00105.5011710.58%
2019/03/251105.0000.00104.0011740.57%
2019/03/0600.002113.25114.50-2186-1.07%
2019/02/262112.501111.00111.0011790.56%
2019/02/2500.003111.67112.00-3178-1.68%
2019/02/191101.0000.00101.5011540.65%
2019/01/0800.00289.1588.90-2111-1.80%
2019/01/03188.5000.0090.0011120.89%
2019/01/0200.00187.4086.20-1109-0.92%
2018/12/28188.7000.0088.6011070.93%
2018/12/2400.00191.1090.10-1112-0.89%
2018/12/1800.00192.0090.50-1104-0.96%
2018/12/13387.7000.0091.503983.06%
2018/11/0500.00180.2081.00-1113-0.88%
2018/11/02181.8000.0082.3011140.88%
2018/10/23189.0000.0088.1011420.70%
2018/10/1600.00193.0093.00-1150-0.67%
2018/10/12192.0000.0093.0011510.66%
2018/10/0400.00199.60105.00-1160-0.62%
2018/09/21199.9000.00102.0011620.62%
2018/07/3000.001129.00129.00-1246-0.41%
2018/07/2000.001124.50122.50-1298-0.34%
2018/07/181126.5000.00125.5013090.32%
2018/05/182135.0000.00136.5024570.44%
2018/05/0400.001139.50147.00-1381-0.26%
2018/04/2700.002110.00117.00-2344-0.58%
2018/04/261115.0000.00110.0013560.28%
2018/04/251116.0000.00117.0013530.28%
2018/04/231112.5000.00117.5013440.29%
2018/04/1900.003111.67111.00-3333-0.90%
2018/04/1800.001110.00114.00-1327-0.31%
2018/04/173105.0000.00104.0033190.94%
2018/04/133106.671108.00105.0023100.64%
2018/04/122116.5000.00116.0023020.66%
2018/03/2200.00398.2093.00-3201-1.49%
2018/03/21399.1700.00102.0031911.56%
2018/02/2100.00177.6077.90-1138-0.72%
2018/02/0800.00175.2075.00-1138-0.72%
2018/02/07175.7000.0075.9011370.73%
2018/01/29190.0000.0089.3011260.79%
2018/01/2500.00188.6087.00-1122-0.82%
2018/01/24189.0000.0088.9011190.84%
2018/01/2300.00188.0088.00-1116-0.86%
2018/01/2200.00192.3090.10-1105-0.94%
〈熱門股〉次世代基因定序明年納健保 創源、慧智帶量上攻Anue鉅亨-2023/08/05
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
慧智 相關文章
慧智 相關影音